Comparison of Endoscopic Ultrasound, Computed Tomography and Magnetic Resonance Imaging for Preoperative Tumor-Size Assessment in Resected Pancreatic Neoplasms

Pancreatic cancer is a formidable disease, and its outcome often hinges on a single, critical detail: how big the tumor is. In the medical world, the size of a growth helps doctors decide how far the cancer has spread, whether it can be removed with surgery, and what kind of treatment plan offers the best chance for survival. To find this size, doctors rely on advanced cameras that look inside the body. The most common tools are computed tomography, which uses X-rays to build cross-sectional images, and magnetic resonance imaging, which uses magnetic fields to create detailed pictures. A third tool, endoscopic ultrasound, involves a flexible tube with a tiny camera and a sound-wave generator that is passed down the throat to get a close-up view of the pancreas. While all three methods are standard, doctors have long noticed that the size they see on these scans does not always match the size of the tumor once it is physically removed and measured by a pathologist. This gap between the picture and the reality can lead to misjudgments about how serious the disease is.

A team of researchers at the National Defense Medical University in Taiwan set out to solve this puzzle by comparing how well each of these three imaging tools actually measures the size of pancreatic tumors. They looked back at the records of 60 patients who had undergone surgery to remove a pancreatic tumor. For every patient, the researchers gathered the measurements taken before the operation by the ultrasound, the CT scan, or the MRI. They then compared these pre-surgery numbers against the "gold standard": the actual size of the tumor measured by hand on the fresh tissue after it was removed from the body. The goal was simple but vital: to see which machine gave the number closest to the truth.

The study focused heavily on tumors that were smaller than 40 millimeters, a size that marks an important boundary in how doctors classify the disease. In this group of smaller tumors, the endoscopic ultrasound proved to be the most precise tool. On average, the measurements taken by the ultrasound were off by only 0.41 centimeters compared to the actual surgical specimen. The magnetic resonance imaging was close behind, with an average difference of 0.47 centimeters, while the computed tomography scans showed a larger average gap of 0.68 centimeters. When the researchers compared the ultrasound directly against the CT scans for the same patients, the ultrasound was statistically more accurate. However, when they compared the ultrasound to the MRI, the difference was so small that it could not be considered significant; both were highly reliable for these smaller growths.

The picture changed slightly when the researchers looked at the larger tumors, those exceeding 40 millimeters. In this category, the study found no meaningful difference in accuracy between the three methods; all three tools performed similarly. The researchers also examined whether the machines tended to consistently overestimate or underestimate the size. They found that the ultrasound had a slight tendency to underestimate the size of larger tumors, meaning the numbers it gave were a bit smaller than the actual tissue, but this bias was not a major issue for the smaller tumors where the tool excelled.

These findings suggest that for smaller pancreatic tumors, the endoscopic ultrasound is a superior tool for getting an exact size, outperforming the standard CT scan and matching the high precision of the MRI. This matters because knowing the exact size helps doctors stage the cancer correctly and decide if a patient is a candidate for surgery or needs other treatments first. The researchers noted that their study had limitations, such as the relatively small number of patients and the fact that it only included people who were well enough to have surgery, which means the results might not apply to every patient with pancreatic cancer. Nevertheless, the data provides a clear signal that for smaller lesions, bringing the ultrasound probe close to the pancreas yields a measurement that is closer to reality than looking from a distance with a CT scanner. The authors conclude that while the ultrasound is not a replacement for the other scans, it serves as a powerful complement, offering a level of detail that can refine the preoperative assessment and potentially improve the care plan for patients facing this difficult disease.